Who has invested in Navigator Medicines?

RA Capital Management, Forbion are named among the investors backing Navigator Medicines.

Navigator Medicines Funding: $100M Raised, Series A (2024)

Navigator Medicines funding overview

Navigator Medicines has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in August 2024. The round record for Navigator Medicines runs through 2024; nothing later has been disclosed. Investors on record include RA Capital Management, Forbion. 2 distinct backers are named across the disclosed rounds.

Navigator Medicines at a glance

Total raised: $100M
Latest round: Series A
Latest round date: August 2024
Notable investors: RA Capital Management, Forbion

Frequently asked about Navigator Medicines funding

How much has Navigator Medicines raised?: Navigator Medicines has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Navigator Medicines?: RA Capital Management, Forbion are named among the investors backing Navigator Medicines.
What was the latest Navigator Medicines funding round?: The most recent disclosed round is a Series A, announced in August 2024.
Where is Navigator Medicines based?: No headquarters location is disclosed for Navigator Medicines.
When did Navigator Medicines last raise?: The last disclosed Navigator Medicines round closed in August 2024 at Series A.

Navigator Medicines totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies below to benchmark round size and investor mix.

Navigator Medicines Funding: $100M Raised, Series A (2024)

Navigator Medicines funding overview

Navigator Medicines at a glance

Frequently asked about Navigator Medicines funding

Companies related to Navigator Medicines (18)

Browse related funding lists (5)